Compare PSO & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSO | BRKR |
|---|---|---|
| Founded | 1844 | 1960 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Books | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 7.0B |
| IPO Year | 2000 | 2000 |
| Metric | PSO | BRKR |
|---|---|---|
| Price | $13.95 | $45.10 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $46.45 |
| AVG Volume (30 Days) | 797.4K | ★ 2.4M |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | ★ 2.34% | 0.44% |
| EPS Growth | ★ 31.65 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $4,822,578,436.00 | $3,438,900,000.00 |
| Revenue This Year | $2.34 | $3.61 |
| Revenue Next Year | $5.09 | $1.23 |
| P/E Ratio | $14.69 | ★ N/A |
| Revenue Growth | N/A | ★ 6.10 |
| 52 Week Low | $12.85 | $28.53 |
| 52 Week High | $17.90 | $64.64 |
| Indicator | PSO | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 64.07 | 51.48 |
| Support Level | $13.03 | $44.96 |
| Resistance Level | $14.06 | $47.88 |
| Average True Range (ATR) | 0.13 | 1.82 |
| MACD | 0.14 | -0.55 |
| Stochastic Oscillator | 89.64 | 2.89 |
UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualification testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.